Brasil -
português -
ANVISA (Agência Nacional de Vigilância Sanitária)
cervarix
glaxosmithkline brasil ltda - hpv-16 l1 , hpv-18 l1 - vacinas
Brasil -
português -
ANVISA (Agência Nacional de Vigilância Sanitária)
hyzaar
organon farmacÊutica ltda. - losartana potássica, hidroclorotiazida - anti-hipertensivos
União Europeia -
português -
EMA (European Medicines Agency)
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
Brasil -
português -
ANVISA (Agência Nacional de Vigilância Sanitária)
vzom
camber farmaceutica ltda - voriconazol - antimicoticos sistemicos
União Europeia -
português -
EMA (European Medicines Agency)
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
Brasil -
português -
ANVISA (Agência Nacional de Vigilância Sanitária)
camptrix
laboratÓrio quÍmico farmacÊutico bergamo ltda - cloridrato de irinotecano triidratado - antineoplasico
Brasil -
português -
ANVISA (Agência Nacional de Vigilância Sanitária)
evoterin
wyeth indÚstria farmacÊutica ltda - antineoplasico
União Europeia -
português -
EMA (European Medicines Agency)
lextemy
mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - agentes antineoplásicos - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.
Brasil -
português -
ANVISA (Agência Nacional de Vigilância Sanitária)
evoterin
farmarin industria e comercio ltda - cloridrato de irinotecano triidratado - antineoplasico
Brasil -
português -
ANVISA (Agência Nacional de Vigilância Sanitária)
proto-itecan
antibiÓticos do brasil ltda - cloridrato de irinotecano triidratado - antineoplasico